Answers are grounded in this paper and cite their sources.
Background: Tamarindus indica seeds are widely used in traditional medicine, but their systemic safety remains inadequately characterized. This study evaluated the 28-day sub-acute toxicological and therapeutic effects of aqueous and ethanolic T. indica seed extracts in Wistar albino rats. Methods: Following phytochemical screening and acute toxicity testing (Lorke's method), 40 rats received oral aqueous or ethanolic extracts (150, 350, or 600 mg/kg) daily for 28 days. Haematological, biochemical (hepatic, renal, lipid, and oxidative stress), and histopathological assessments were performed. Results: Both extracts exhibited high acute safety (LD50 > 5000 mg/kg). The aqueous extract showed a favourable safety profile, preserving liver and kidney architecture while significantly reducing triglycerides and increasing high-density lipoprotein HDL levels. In contrast, the ethanolic extract enhanced intestinal superoxide dismutase activity but caused dose-dependent hepatic necrosis, renal damage, and reduced haemoglobin synthesis. 150, 350 and 600 mg/kg of both extracts produced cardiotoxic effects characterized by myocardial necrosis. Conclusion: T. indica seed extracts possess solvent-dependent therapeutic potential but demonstrate narrow therapeutic windows. Their dose-dependent organ toxicity highlights the need for careful dose optimization and comprehensive safety evaluation before clinical application.
No takes yet. Share an insight, caveat, or question.
Zataat et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: